Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Advertising Osteo Bi-Flex glucosamine/chondroitin dietary supplement in Arthritis Foundation "Help is in your grasp" magazine brochure insert. The supplement marketer also has made a $125,000 general donation to the foundation and is using the AF logo in other advertising along with a statement disclosing its funding of the group. The educational brochure, with warnings signs for osteoarthritis and tips for living with the condition, is in May Reader's Digest "mature" circulation and large print issues as well as New Choices magazine. Other advertisers include McNeil Consumer Healthcare (Tylenol), Pfizer (Ultra Strength Bengay) and Searle (Rx Celebrex). Ads in the leaflet bear the "Help is in your grasp" insignia with the Arthritis Foundation logo in the center
Advertisement

Related Content

Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1
Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1
Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results
Rexall Osteo-Bi-Flex 27% Sales Growth Paces Strong FY 1999 Results

Topics

Advertisement
UsernamePublicRestriction

Register

PS089827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel